One Africa-One Market - Your Borderless B2B Sourcing Portal

Become a Merchant

مرحبا بك في Zandaux

  • تسجيل دخول البائع
  • أتبع طلبك
  • يدعم
Kenyan Products
Blenrep - BULK PURCHASE | MOQ 1 CARTON
التوفر:
في الأوراق المالية
حالة:
New
طلب اقتباس
تم بيعها من قبل نظرة سريعة
Kenyan Products
شعار Kenya

مفتاح الميزات

  • MOQ 1 CARTON
  • Targets Multiple Myeloma Cells: Blenrep specifically targets a protein called BCMA, which is found on the surface of multiple myeloma cells.
  • Triggers Immune System Response: Once attached to BCMA, Blenrep recruits other immune cells to help destroy the cancer cells.
  • Approved for Relapsed/Refractory Multiple Myeloma: Blenrep is indicated for adults with multiple myeloma who have received at least three prior lines of therapy.
  • Potential for Improved Outcomes: In clinical studies, Blenrep has shown promising results in terms of response rates and progression-free survival.

Blenrep (belantamab mafodotine-awof) is a monoclonal antibody designed to treat multiple myeloma, a type of cancer that affects plasma cells.


تفاصيل تقنية:

UPC: gsk-0000038
رمز SKU للبائع: gsk-0000038
حالة: New
التوفر: في الأوراق المالية
أقل كمية ممكن طلبها: 1
التاريخ المدرج لأول مرة على Zandaux: Sep 17, 2024

Blenrep (belantamab mafodotine-awof) is a monoclonal antibody designed to treat multiple myeloma, a type of cancer that affects plasma cells.

  • Targets Multiple Myeloma Cells: Blenrep specifically targets a protein called BCMA, which is found on the surface of multiple myeloma cells.
  • Triggers Immune System Response: Once attached to BCMA, Blenrep recruits other immune cells to help destroy the cancer cells.
  • Approved for Relapsed/Refractory Multiple Myeloma: Blenrep is indicated for adults with multiple myeloma who have received at least three prior lines of therapy.
  • Potential for Improved Outcomes: In clinical studies, Blenrep has shown promising results in terms of response rates and progression-free survival.

لم يتم تقديم تعليقات

busy...
Kenyan Products
(متصل)

نحن على بعد خطوة واحدة فقط! الرجاء تسجيل الدخول لبدء المحادثة. تسجيل الدخول